Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade in Active Ankylosing Spondylitis
NCT00779012Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Jun 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in ankylosing spondylitis (AS), sponsored by Merck & Co.. Started Oct 2004; status: completed.
02
Drugs
infliximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00779012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779012.